EDITORIAL article
Front. Nutr.
Sec. Nutritional Epidemiology
Volume 12 - 2025 | doi: 10.3389/fnut.2025.1632666
This article is part of the Research TopicThe Role of Foods, Diet, and Dietary Patterns in the Prevention and Management of DiabesityView all 9 articles
Editorial: The Role of Foods, Diet, and Dietary Patterns in the Prevention and Management of Diabesity
Provisionally accepted- Departamento de Nutrição, Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM), Diamantina, Brazil
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
due to the variability of carbohydrate restrictions, the authors reinforce the need for further research to standardize dietary guidelines and evaluate long-term effects.The fifth study (https://doi.org/10.3389/fnut.2024.1510096), a cross-sectional analysis of four waves of data from the National Health and Nutritional Examination Surveys (NHANES) between 2013-2020, assessed the association between vitamin B2 intake and diabetes (DM) among adults in the US. It was found that vitamin B2 intake was significantly associated with DM in women but not in men. Each standard deviation increase in vitamin B2 intake was associated with a 19% reduction in the odds of DM in women. It is noteworthy, however, that this study did not identify the type of diabetes, and type I diabetes is unrelated to dietary intake or behavior.The sixth study (https://doi.org/10.3389/fnut.2024.1520779) aimed to predict the effectiveness of inulin treatment for T2DM using a machine learning model (XGBoost-SHAP model). In this study, from T2DM patients, 477 (62.93%) achieved HbA1c <6.5% post-inulin treatment. LASSO regression identified six key predictors of treatment success. They used an XGBoost algorithm, which was evaluated by performance metrics (accuracy, specificity, positive/negative predictive values) and interpretability (SHAP analysis ranked feature importance). The XGBoost-SHAP model successfully identified T2DM patients likely to respond to inulin, enabling personalized nutrition therapy. The learning model could guide clinicians in selecting candidates for the inulin intervention. However, they warned that the model must be validated in diverse populations, and exploring additional biomarkers (e.g., gut microbiota profiles) is necessary.The seventh study (https://doi.org/10.3389/fnut.2024.1495792), developed with data from NHANES participants from 2005 to 2018, investigated whether there is an association between cardiometabolic indexes (CMI) and frailty index (FI) in patients with DM. CMI is a new marker of metabolic status and is calculated by the formula: CMI = [WC (cm)/height (cm)] × (TG/HDL-c), and the FI was evaluated. The FI considered seven domains and 49 items, which included cognition, dependence, depressive symptoms, comorbidities, physical performance and anthropometry, hospital use and access to care, and laboratory tests. The authors found that the higher the CMI, the higher the FI in participants with DM. This study also did not classify the type of diabetes; however, CMI is an indicator that can reflect both obesity and lipids and can be used to identify DM (12) and elevated glycated hemoglobin (13). Thus, this study indirectly indicated that CMI reflects diabesity in participants, and having this problem favors a higher rate of frailty. The authors conclude that maintaining a healthy, low-fat dietary pattern and adequately controlling blood lipid levels can reduce the risk of frailty in people with DM.The eighth study (https://doi.org/10.3389/fnut.2024.1473429) discusses the prevalence and impact of nutritional diagnoses in individuals with type 2 diabetes (T2D). The study used the Nutrition Care Process (NCP) model to assess and diagnose patients, finding that the most common nutritional diagnosis was excessive energy and carbohydrate intake. The study analyzed data from 2,050 patients and found that dietary diagnoses in the intake domain, followed by the behavioral/environmental and clinical domains, are highly prevalent in people with T2D. These diagnoses are associated with poorer metabolic control, higher BMI, and increased energy and carbohydrate intake. The research emphasizes the importance of timely identification of nutritional problems to improve disease control and promote a healthy lifestyle.While these findings advance our understanding of diabesity management, further research is needed to standardize dietary recommendations, explore long-term effects, and validate interventions across diverse populations. Addressing diabesity requires a multifaceted approach, integrating evidencebased nutrition, personalized medicine, and public health strategies to mitigate its growing burden. By prioritizing dietary modifications and early intervention, healthcare providers can better support individuals in achieving metabolic health and reducing diabesity-related complications Keywords: Diabesity. Foods. Diet. Treatment. Health strategies
Keywords: Diabesity, foods, Diet, dietary pattens, prevention
Received: 21 May 2025; Accepted: 03 Jun 2025.
Copyright: © 2025 Nobre and Esteves. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Luciana Neri Nobre, Departamento de Nutrição, Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM), Diamantina, Brazil
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.